Literature DB >> 30248190

Developmental Changes in Pharmacokinetics and Pharmacodynamics.

John van den Anker1,2,3, Michael D Reed4, Karel Allegaert3,5,6, Gregory L Kearns7.   

Abstract

Effective drug therapy to optimally influence disease requires an understanding of a drug's pharmacokinetic, pharmacodynamic, and pharmacogenomic interrelationships. In pediatrics, age is a continuum that can and does add variability in drug disposition and effect. This article addresses the many important factors that influence drug disposition and effect relative to age. What is known about the influence of maturation on the processes of drug absorption, distribution, metabolism, excretion, and drug receptor dynamics are outlined. Our state of understanding of many of these factors remains in flux, however, and only with additional study will we be able to better anticipate and model drug-response relationships across the age continuum. Being able to continuously improve our care of the ill pediatric patient while simultaneously being able to accurately determine the utility of new drugs and chemical entities in this population requires our enhanced understanding of these disposition characteristics.
© 2018, The American College of Clinical Pharmacology.

Entities:  

Keywords:  developmental pharmacology; drug transporters; drug-metabolizing enzymes; pediatric pharmacology; pharmacodynamics; pharmacokinetics

Mesh:

Substances:

Year:  2018        PMID: 30248190     DOI: 10.1002/jcph.1284

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  46 in total

1.  Methadone dosing strategies in preterm neonates can be simplified.

Authors:  Tamara van Donge; Samira Samiee-Zafarghandy; Marc Pfister; Gilbert Koch; Majid Kalani; Arash Bordbar; John van den Anker
Journal:  Br J Clin Pharmacol       Date:  2019-04-10       Impact factor: 4.335

2.  Paediatric extrapolation: the panacea for paediatric drug development?

Authors:  John van den Anker
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

3.  Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia.

Authors:  Laurent M A Favié; Floris Groenendaal; Marcel P H van den Broek; Carin M A Rademaker; Timo R de Haan; Henrica L M van Straaten; Peter H Dijk; Arno van Heijst; Sinno H P Simons; Koen P Dijkman; Monique Rijken; Inge A Zonnenberg; Filip Cools; Alexandra Zecic; Johanna H van der Lee; Debbie H G M Nuytemans; Frank van Bel; Toine C G Egberts; Alwin D R Huitema
Journal:  Neonatology       Date:  2019-06-28       Impact factor: 4.035

4.  LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner.

Authors:  Yi Zheng; Pan-Pan Ye; Yue Zhou; Su-Ying Wu; Xi-Ting Liu; Bin Du; Bo-Hao Tang; Min Kan; Ai-Qing Nie; Rui Yin; Meng Wang; Guo-Xiang Hao; Lin-Lin Song; Xin-Mei Yang; Xin Huang; Le-Qun Su; Wen-Qi Wang; John van den Anker; Wei Zhao
Journal:  J Inflamm Res       Date:  2021-08-03

5.  A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age-dependent differences in absorption.

Authors:  Eva J Streekstra; Márton Kiss; Jeroen van den Heuvel; Johan Nicolaï; Petra van den Broek; Sanne M B I Botden; Martijn W J Stommel; Lara van Rijssel; Anna-Lena Ungell; Evita van de Steeg; Frans G M Russel; Saskia N de Wildt
Journal:  Clin Transl Sci       Date:  2022-08-12       Impact factor: 4.438

6.  Pediatric Perioperative Clinical Pharmacy Practice: Clinical Considerations and Management: An Opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy.

Authors:  Elizabeth J Beckman; Sara Hovey; Deborah S Bondi; Gourang Patel; Richard H Parrish
Journal:  J Pediatr Pharmacol Ther       Date:  2022-08-19

7.  [Pharmacogenomics: precision tool in routine prescription].

Authors:  Bing Yu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

8.  Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir.

Authors:  Xiaomei I Liu; Jeremiah D Momper; Natella Y Rakhmanina; Dionna J Green; Gilbert J Burckart; Tim R Cressey; Mark Mirochnick; Brookie M Best; John N van den Anker; André Dallmann
Journal:  Clin Pharmacokinet       Date:  2021-02-02       Impact factor: 5.577

9.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 10.  Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.

Authors:  Nutthapoom Pathomthongtaweechai; Chatchai Muanprasat
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.